This project has been flagged by a community member as inappropriate due to reason below.*

Survey

Slingshot members are conducting a survey! The topic is:

Quarterly Survey: Depression Bipolar Disorder Treatments and AXSM's Auvelity and ITCI's Caplyta April 2024

Ticker(s): AXSM, ITCI, TAK

Who's being surveyed?

The survey results include 20 Psychiatrists.

Survey Questions
Q1.

Are you familiar with Auvelity (dextromethorphan HBr-bupropion HCl) and data to date?

Q2.

Are you familiar with Caplyta (lumateperone) and data to date?

Q3.

How would you best describe your practice?

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.